Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

Recommend :
React to this article
4d ago SWEDISH ORPHAN BIOVITRUM : Sobi Becomes Market Authorisation Holder For Xiapex i..
6d ago AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
6d ago AUXILIUM PHARMACEUTICALS : and Sobi Announce Encore Presentation of XIAFLEX/Xiap..
04/07 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
04/07 AUXILIUM PHARMACEUTICALS : Sobi Becomes Market Authorisation Holder For Xiapex i..
04/07 SWEDISH ORPHAN BIOVITRUM : Sobi becomes market authorisation holder for Xiapex i..
03/27 AUXILIUM PHARMACEUTICALS : National Law Firm Announces Testim Testosterone Lawsu..
03/17 AUXILIUM PHARMACEUTICALS : To Present At The Cowen And Company Annual Healthcare..
03/17 AUXILIUM PHARMACEUTICALS : To Ring the NASDAQ Stock Market Opening Bell On Febru..
03/17 AUXILIUM PHARMACEUTICALS : To Announce Fourth Quarter And Full Year 2013 Results..
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
Dynamic quotes